ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,590Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 337

$888K Total Retail Price of All Prescriptions

Rank: 17 out of 337

301 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 301 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 301 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 14,098 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 938 849 1 11
TRAZODONE HCL 633 592 2 16
FUROSEMIDE 625 570 3 8
SIMVASTATIN 504 462 4 1
LISINOPRIL 484 441 5 2
LEVOTHYROXINE SODIUM 461 412 6 5
AMLODIPINE BESYLATE 445 426 7 3
METOPROLOL TARTRATE 421 374 8 6
SERTRALINE HCL 358 358 9 18
OMEPRAZOLE 334 306 10 4
DONEPEZIL HCL 309 296 11 22
HYDROCODONE-ACETAMINOPHEN 296 267 S3 12 13
NAMENDA 255 255 13 35
GABAPENTIN 243 196 14 20
MIRTAZAPINE 226 216 15 27
PRAVASTATIN SODIUM 198 178 16 14
ATENOLOL 188 172 17 10
POLYETHYLENE GLYCOL 3350 177 176 18 47
METFORMIN HCL 168 140 19 12
ALENDRONATE SODIUM 160 133 20 19
GLIPIZIDE 150 150 21 45
PANTOPRAZOLE SODIUM 147 141 22 36
CARBIDOPA-LEVODOPA 131 131 23 92
TAMSULOSIN HCL 124 95 24 25
LANTUS 121 82 25 49
LOSARTAN POTASSIUM 119 119 26 15
ATORVASTATIN CALCIUM 117 100 27 7
CITALOPRAM HBR 111 102 28 17
TRAMADOL HCL 102 94 29 32
CYMBALTA 98 90 30 59
CEPHALEXIN 97 88 31 130
HYDROCHLOROTHIAZIDE 96 96 32 9
DILTIAZEM 24HR CD 96 86 32 104
CIPROFLOXACIN HCL 94 94 34 71
BISOPROLOL FUMARATE 92 92 35 67
FENOFIBRATE 92 79 35 48
RISPERIDONE 90 89 37 72
ESCITALOPRAM OXALATE 83 80 38 66
NOVOLIN 70-30 79 79 39 198
ALLOPURINOL 76 76 40 28
LIDODERM 75 57 41 82
DIOVAN 74 52 42 26
METOPROLOL SUCCINATE 74 74 42 21
DIGOXIN 74 67 42 58
FAMOTIDINE 74 74 42 115
RANITIDINE HCL 73 69 46 30
POTASSIUM CHLORIDE 72 72 47 62
CLOPIDOGREL 72 64 47 42
ZOLPIDEM TARTRATE 71 36 49 23
CRESTOR 69 50 50 29
ENALAPRIL MALEATE 67 67 51 37
KLOR-CON M20 67 62 51 65
ADVAIR DISKUS 64 63 53 44
NOVOLOG 64 52 53 106
LEVEMIR 64 57 53 299
LEVOFLOXACIN 64 62 53 93
LEVETIRACETAM 62 62 57 112
VENLAFAXINE HCL ER 62 51 57 86
NIASPAN 59 47 59 157
FLUTICASONE PROPIONATE 59 42 59 34
NOVOLOG MIX 70-30 58 58 61 249
ISOSORBIDE MONONITRATE ER 58 46 61 70
FINASTERIDE 58 51 61 83
PLAVIX 57 53 64 74
GLIPIZIDE ER 54 54 65 69
TAMIFLU 53 49 66 147
OLANZAPINE 53 53 66 108
SPIRIVA 52 52 68 43
LATANOPROST 52 52 68 120
OXYCODONE-ACETAMINOPHEN 50 35 S2 70 84
BYSTOLIC 50 50 70 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.